Similarly, in some cancer cells where the activation of mGluRs is tumor-promoting such as mGluR8, the heterodimerization of the receptor with another receptor could enhance the efficacity of the antagonist in the inhibition of tumor growth. This evidence concerns the gene GRM8 and neoplasm.